129 related articles for article (PubMed ID: 9234265)
1. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
[TBL] [Abstract][Full Text] [Related]
2. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
[TBL] [Abstract][Full Text] [Related]
3. Discriminated release of a hippurate-like radiometal chelate in nontarget tissues for target-selective radioactivity localization using pH-dependent dissociation of reduced antibody.
Arano Y; Inoue T; Mukai T; Wakisaka K; Sakahara H; Konishi J; Yokoyama A
J Nucl Med; 1994 Feb; 35(2):326-33. PubMed ID: 8295006
[TBL] [Abstract][Full Text] [Related]
4. Stability of a metabolizable ester bond in radioimmunoconjugates.
Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
[TBL] [Abstract][Full Text] [Related]
6. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
7. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
8. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
9. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
10. In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody.
Sakahara H; Saga T; Endo K; Hattori N; Hosono M; Kobayashi H; Shirato M; Yamamuro T; Toyama S; Arano Y
Nucl Med Biol; 1993 Jul; 20(5):617-23. PubMed ID: 8358347
[TBL] [Abstract][Full Text] [Related]
11. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
[TBL] [Abstract][Full Text] [Related]
12. Manipulating the In Vivo Behaviour of
Imberti C; Adumeau P; Blower JE; Al Salemee F; Baguña Torres J; Lewis JS; Zeglis BM; Terry SYA; Blower PJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098299
[TBL] [Abstract][Full Text] [Related]
13. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
Quadri SM; Vriesendorp HM
Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
[TBL] [Abstract][Full Text] [Related]
14. In vivo radiolocalization of antiosteogenic sarcoma monoclonal antibodies in osteogenic sarcoma xenografts.
Nakamura T; Sakahara H; Hosoi S; Yamamuro T; Higashi S; Mikawa H; Endo K; Toyama S
Cancer Res; 1984 May; 44(5):2078-83. PubMed ID: 6585270
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity.
Kobayashi H; Sato N; Saga T; Nakamoto Y; Ishimori T; Toyama S; Togashi K; Konishi J; Brechbiel MW
Eur J Nucl Med; 2000 Sep; 27(9):1334-9. PubMed ID: 11007515
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins.
Kojima S; Jay M
Eur J Nucl Med; 1987; 13(7):366-70. PubMed ID: 3428286
[TBL] [Abstract][Full Text] [Related]
17. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
Yamaoka S
Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
[TBL] [Abstract][Full Text] [Related]
18. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
[TBL] [Abstract][Full Text] [Related]
19. Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.
Koizumi K; Tonami N; Hisada K
Eur J Nucl Med; 1982; 7(5):229-33. PubMed ID: 6954069
[TBL] [Abstract][Full Text] [Related]
20. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
